BioCentriq Appoints Syed T. Husain as Chief Executive Officer
Newark, NJ, September 19, 2024 – BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announces that it has appointed Syed T. Husain as its new Chief Executive Officer (CEO), and as …
Read more